Eli Lilly and Regeneron Join FDA Pilot Program to Enhance US Drug Manufacturing
The U.S. Food and Drug Administration (FDA) has selected Eli Lilly (LLY) and Regeneron Pharmaceuticals (REGN), among seven other drug companies, for its PreCheck Pilot Program aimed at strengthening domestic pharmaceutical manufacturing capabilities.
Topics: manufacturing pharmaceuticals regulation